首页> 外文期刊>The Clinical biochemist. Reviews >Managing the Ethical Issues of Genomic Research using Pathology Specimens1
【24h】

Managing the Ethical Issues of Genomic Research using Pathology Specimens1

机译:使用病理标本管理基因组研究的伦理问题

获取原文
获取原文并翻译 | 示例
       

摘要

Biobanks of human biospecimens involving tissue taken from surgery require close relationships with diagnostic pathology practices. As most of the tissue will be analysed using genetic or genomic technologies there is the possibility that new information is created that could be of relevance to the donors. Although attention has been recently focused on the responsibilities that may arise from researchers and biobanks in terms of giving back individual genetic research results (IGRRs) to research participants, little has been said in relation to the role of pathology services. In this Commentary, we summarise the issues with respect to pathology services and what guidelines and professional practice documents say about their responsibilities. We also provide points to consider in the development of an ethically defensible plan for giving back individual research results.
机译:涉及从手术中获取的组织的人类生物标本的生物库需要与诊断病理学实践密切相关。由于大多数组织将使用遗传或基因组技术进行分析,因此有可能会创建与供体相关的新信息。尽管最近注意力已集中在研究人员和生物库在将个体遗传研究结果(IGRR)退还给研究参与者方面可能承担的责任上,但对于病理学服务的作用却知之甚少。在本评论中,我们总结了与病理服务有关的问题,以及有关指导方针和专业实践文件的职责。我们还提供了一些值得考虑的观点,以制定可辩护的道德计划,以退还个别研究结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号